Avid Bioservices provided earnings guidance for fiscal Year 2025. For the period, the company expects revenue of $160 million to $168 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.42 USD | -3.64% |
|
+3.92% | +14.15% |
02/07 | Avid Bioservices Fiscal Q4 Loss Widens, Revenue Increases; Fiscal 2025 Revenue Outlook Set | MT |
02/07 | Transcript : Avid Bioservices, Inc., Q4 2024 Earnings Call, Jul 02, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.15% | 472M | |
+4.57% | 97.7B | |
+5.66% | 41.43B | |
-12.80% | 32.85B | |
+80.99% | 29.33B | |
-15.53% | 15.47B | |
-8.70% | 12.89B | |
-12.22% | 11.51B | |
+183.25% | 10.74B | |
-55.41% | 8.97B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Avid Bioservices Provides Earnings Guidance for Fiscal Year 2025